Skip Navigation
Skip to contents

J Korean Diabetes Assoc.  2007 Nov;31(6):465-471. 10.4093/jkda.2007.31.6.465.

Comparison of Minicircle with Conventional Plasmid for the Non-viral Vascular Endothelial Growth Factor (VEGF) Gene Therapy

Affiliations
  • 1Paik Diabetes Center, Division of Endocrinology & Metabolism, Pusan Paik Hospital, College of Medicine, Inje University.
  • 2Molecular Therapy Lab, Paik Memorial Institute for Clinical Research, Inje University.
  • 3Department of Internal Medicine, Maryknoll General Hospital.

Abstract

BACKGROUND: Delayed wound healings in diabetic patients are related with the impairment of the expressions of various growth factors. Treatments using growth factors have been attempted on diabetic foot ulcer. VEGF (vascular endothelial growth factor) accelerates neo-angiogenesis on the early phase of the wound healing and exerts chemo-attractive effect for the other growth factors and cytokines. Non-viral gene transfer strategies are attractive tool for the gene therapy due to the safety and the versatility, but the low efficiency has been the serious problem.
METHODS
We performed the VEGF gene therapy using reconstructed minicircle MINI-pbetaVEGF DNA with a polymeric carrier, polyethylenimine (PEI, 25 kDa) in HEK293, CHO, and NIH3T3 cell lines, and compared its efficiency with the conventional VEGF plasmid pbetaVEGF.
RESULTS
The levels of expressed VEGF were higher in the groups using BPEI (branched PEI) as a gene carrier than naked plasmid transfer in all cell lines (P < 0.05). The minicircle MINI-pbetaVEGF DNA showed much higher VEGF expression than conventional plasmid pbetaVEGF (P < 0.05).
CONCLUSION
Minicircle DNA MINI-pbetaVEGF showed much higher transfection efficiency than conventional plasmid pbetaVEGF. It might be used in actual human clinical trial due to its higher efficiency and possible safety for the treatment of diabetic foot ulcer.

Keyword

Gene therapy; Minicircle DNA; Vascular endothelial growth factor (VEGF)

MeSH Terms

Cell Line
Cytokines
Diabetic Foot
DNA
Genes, vif
Genetic Therapy*
Humans
Intercellular Signaling Peptides and Proteins
Plasmids*
Polyethyleneimine
Polymers
Transfection
Ulcer
Vascular Endothelial Growth Factor A*
Wound Healing
Cytokines
DNA
Intercellular Signaling Peptides and Proteins
Polyethyleneimine
Polymers
Vascular Endothelial Growth Factor A
Full Text Links
  • JKDA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr